Dudediligence.

Bicara Therapeutics Inc

BCAXNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$16.3M

53 notices · 736,405 sh

Oct 2025 to Oct 2026

Reported ·

$11.6M

64 sales · 1 buy · $4,800,000 bought

Oct 2025 to Sep 2026

The two figures cover different periods.

All 64 reported sales carry the 10b5-1 box. Together they are 0.83% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2026-09-08: Hyep Ivan, Form 1442026-09-08: Cohlhepp Ryan, Form 1442026-08-10: Hyep Ivan, Form 1442026-08-10: Cohlhepp Ryan, Form 1442026-08-10: Mazumdar Claire, Form 1442026-07-10: Mazumdar Claire, Form 1442026-07-08: Cohlhepp Ryan, Form 1442026-07-08: Hyep Ivan, Form 1442026-07-08: DAVID RABEN, Form 1442026-07-07: Lara Meisner, Form 1442026-06-25: DAVID RABEN, Form 1442026-06-01: Meisner Lara, Form 1442026-05-26: Raben David, Form 1442026-05-21: Hyep Ivan, Form 1442026-05-18: Mazumdar Claire, Form 1442026-05-15: Cohlhepp Ryan, Form 1442026-04-27: Raben David, Form 1442026-04-21: Hyep Ivan, Form 1442026-04-20: Mazumdar Claire, Form 1442026-04-15: Cohlhepp Ryan, Form 1442026-03-25: Raben David, Form 1442026-03-23: Hyep Ivan, Form 1442026-03-20: Mazumdar Claire, Form 1442026-03-19: Mazumdar Claire, Form 1442026-03-18: Mazumdar Claire, Form 1442026-03-16: Cohlhepp Ryan, Form 1442026-03-09: Mazumdar Claire, Form 1442026-03-06: Mazumdar Claire, Form 1442026-03-05: Mazumdar Claire, Form 1442026-03-04: Hyep Ivan, Form 1442026-03-04: Mazumdar Claire, Form 1442026-03-04: Raben David, Form 1442026-03-03: Hyep Ivan, Form 1442026-03-03: Raben David, Form 1442026-03-03: Cohlhepp Ryan, Form 1442026-02-25: Cohlhepp Ryan, Form 1442026-01-22: Cohlhepp Ryan, Form 1442026-01-22: Hyep Ivan, Form 1442026-01-15: Cohlhepp Ryan, Form 1442025-12-22: Hyep Ivan, Form 1442025-12-15: Cohlhepp Ryan, Form 1442025-11-25: Raben David, Form 1442025-11-24: Mazumdar Claire, Form 1442025-11-24: Hyep Ivan, Form 1442025-11-24: Raben David, Form 1442025-11-21: Hyep Ivan, Form 1442025-11-21: Cohlhepp Ryan, Form 1442025-10-16: Mazumdar Claire, Form 1442025-10-15: Cohlhepp Ryan, Form 1442025-10-15: Mazumdar Claire, Form 1442025-10-13: Mazumdar Claire, Form 1442025-10-09: Hyep Ivan, Form 1442025-10-09: Raben David, Form 1442025-10-09: Hyep Ivan, sold2025-10-09: Raben David, sold2025-10-13: Mazumdar Claire, sold2025-10-15: Cohlhepp Ryan, sold2025-10-16: Mazumdar Claire, sold2025-11-21: Cohlhepp Ryan, sold2025-11-21: Hyep Ivan, sold2025-11-24: Mazumdar Claire, sold2025-11-24: Raben David, sold2025-12-15: Cohlhepp Ryan, sold2025-12-22: Hyep Ivan, sold2026-01-15: Cohlhepp Ryan, sold2026-01-22: Hyep Ivan, sold2026-01-22: Cohlhepp Ryan, sold2026-02-25: Cohlhepp Ryan, sold2026-02-26: RA Capital Healthcare Fund LP, bought2026-03-03: Raben David, sold2026-03-03: Hyep Ivan, sold2026-03-03: Cohlhepp Ryan, sold2026-03-04: Mazumdar Claire, sold2026-03-09: Mazumdar Claire, sold2026-03-16: Cohlhepp Ryan, sold2026-03-18: Mazumdar Claire, sold2026-03-23: Hyep Ivan, sold2026-03-25: Raben David, sold2026-04-15: Cohlhepp Ryan, sold2026-04-20: Mazumdar Claire, sold2026-04-21: Hyep Ivan, sold2026-04-27: Raben David, sold2026-05-15: Cohlhepp Ryan, sold2026-05-18: Mazumdar Claire, sold2026-05-21: Hyep Ivan, sold2026-07-08: Hyep Ivan, sold2026-07-08: Cohlhepp Ryan, sold2026-07-10: Mazumdar Claire, sold2026-08-10: Cohlhepp Ryan, sold2026-08-10: Mazumdar Claire, sold2026-08-10: Hyep Ivan, sold2026-09-08: Cohlhepp Ryan, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-09-08Hyep Ivan, Chief Financial Officer$283,000
12,500 shplan 2026-03-31Form 4s on file end Sep 23144 ↗
2026-09-08Cohlhepp Ryan, President, COO & Interim CEO$396,200
17,500 shplan 2026-03-31144 ↗
Form 4, 2026-09-10: sold 17,500 at $22.90 Form 4 ↗
2026-08-10Hyep Ivan, Chief Financial Officer$347,875
12,500 shplan 2026-03-31144 ↗
Form 4, 2026-08-12: sold 12,500 at $27.97 Form 4 ↗
2026-08-10Cohlhepp Ryan, President, COO & Interim CEO$521,813
18,750 shplan 2026-03-31144 ↗
Form 4, 2026-08-12: sold 18,750 at $27.98 Form 4 ↗
2026-08-10Mazumdar Claire, Chief Executive Officer$278,300
10,000 shplan 2026-03-31144 ↗
Form 4, 2026-08-12: sold 10,000 at $27.98 Form 4 ↗
2026-07-10Mazumdar Claire, Chief Executive Officer$296,800
10,000 shplan 2026-03-31144 ↗
Form 4, 2026-07-14: sold 10,000 at $28.42 Form 4 ↗
2026-07-08Cohlhepp Ryan, President, COO & Interim CEO$869,688
28,750 shplan 2026-03-31144 ↗
Form 4, 2026-07-10: sold 28,750 at $28.98 Form 4 ↗
2026-07-08Hyep Ivan, Chief Financial Officer$847,000
28,000 shplan 2026-03-31144 ↗
Form 4, 2026-07-10: sold 28,000 at $28.84 Form 4 ↗
2026-07-08DAVID RABEN, Chief Medical Officer$1,428,080
50,000 shplan 2026-03-31Form 4s on file end Sep 23144 ↗
2026-07-07Lara Meisner, Chief Legal Officer$29,774
1,000 shplan 2026-03-31Form 4s on file end Sep 23144 ↗
2026-06-25DAVID RABEN, Chief Medical Officer$1,324,650
50,000 shplan 2026-03-31no Form 4 on file144 ↗
2026-06-01Meisner Lara, Chief Legal Officer$1,473,716
71,390 shplan 2026-03-31no Form 4 on file144 ↗
2026-05-26Raben David, Chief Medical Officer$120,010
5,500 shplan 2025-02-12no Form 4 on file144 ↗
2026-05-21Hyep Ivan, Chief Financial Officer$187,883
9,200 shplan 2025-02-13144 ↗
Form 4, 2026-05-26: sold 9,200 at $20.42 Form 4 ↗
2026-05-18Mazumdar Claire, Chief Executive Officer$313,800
15,000 shplan 2025-02-12144 ↗
Form 4, 2026-05-20: sold 15,000 at $20.04 Form 4 ↗
2026-05-15Cohlhepp Ryan, President, COO & Interim CEO$253,875
12,500 shplan 2025-02-12144 ↗
Form 4, 2026-05-18: sold 12,500 at $20.29 Form 4 ↗
2026-04-27Raben David, Chief Medical Officer$125,830
5,500 shplan 2025-02-12144 ↗
Form 4, 2026-04-28: sold 5,500 at $22.88 Form 4 ↗
2026-04-21Hyep Ivan, Chief Financial Officer$213,210
9,200 shplan 2025-02-13144 ↗
Form 4, 2026-04-22: sold 9,200 at $23.00 Form 4 ↗
2026-04-20Mazumdar Claire, Chief Executive Officer$356,100
15,000 shplan 2025-02-12144 ↗
Form 4, 2026-04-20: sold 15,000 at $23.61 Form 4 ↗
2026-04-15Cohlhepp Ryan, President, COO & Interim CEO$287,250
12,500 shplan 2025-02-12144 ↗
Form 4, 2026-04-17: sold 12,500 at $23.01 Form 4 ↗
2026-03-25Raben David, Chief Medical Officer$104,229
5,500 shplan 2025-02-12144 ↗
Form 4, 2026-03-26: sold 5,500 at $18.95 Form 4 ↗
2026-03-23Hyep Ivan, Chief Financial Officer$171,120
9,200 shplan 2025-02-13144 ↗
Form 4, 2026-03-24: sold 9,200 at $18.52 Form 4 ↗
2026-03-20Mazumdar Claire, Chief Executive Officer$30,246
1,596 shplan 2025-02-12no Form 4 on file144 ↗
2026-03-19Mazumdar Claire, Chief Executive Officer$129,705
6,905 shplan 2025-02-12no Form 4 on file144 ↗
2026-03-18Mazumdar Claire, Chief Executive Officer$124,716
6,499 shplan 2025-02-12144 ↗
Form 4, 2026-03-20: sold 15,000 at $18.82 Form 4 ↗
2026-03-16Cohlhepp Ryan, President, COO & Interim CEO$241,750
12,500 shplan 2025-02-12144 ↗
Form 4, 2026-03-17: sold 12,500 at $19.66 Form 4 ↗
2026-03-09Mazumdar Claire, Chief Executive Officer$704,657
36,766 shplan 2025-02-12144 ↗
Form 4, 2026-03-11: sold 36,766 at $19.17 Form 4 ↗
2026-03-06Mazumdar Claire, Chief Executive Officer$75,572
3,817 shplan 2025-02-12no Form 4 on file144 ↗
2026-03-05Mazumdar Claire, Chief Executive Officer$33,464
1,786 shplan 2025-02-12no Form 4 on file144 ↗
2026-03-04Hyep Ivan, Chief Financial Officer$54,062
2,963 shplan 2025-02-13no Form 4 on file144 ↗
2026-03-04Mazumdar Claire, Chief Executive Officer$49,289
2,631 shplan 2025-02-12144 ↗
Form 4, 2026-03-06: sold 8,234 at $18.74 Form 4 ↗
2026-03-04Raben David, Chief Medical Officer$301,920
16,300 shplan 2025-02-12no Form 4 on file144 ↗
2026-03-03Hyep Ivan, Chief Financial Officer$246,910
13,555 shplan 2025-02-13144 ↗
Form 4, 2026-03-05: sold 16,518 at $18.23 Form 4 ↗
2026-03-03Raben David, Chief Medical Officer$3,690
200 shplan 2025-02-12144 ↗
Form 4, 2026-03-05: sold 16,500 at $18.52 Form 4 ↗
2026-03-03Cohlhepp Ryan, President, COO & Interim CEO$315,893
17,392 shplan 2025-02-12144 ↗
Form 4, 2026-03-05: sold 17,392 at $18.16 Form 4 ↗
2026-02-25Cohlhepp Ryan, President, COO & Interim CEO$65,501
3,631 shplan 2025-02-12144 ↗
Form 4, 2026-02-27: sold 3,631 at $18.04 Form 4 ↗
2026-01-22Cohlhepp Ryan, President, COO & Interim CEO$64,961
3,828 shplan 2025-02-12144 ↗
Form 4, 2026-01-26: sold 3,828 at $18.10 Form 4 ↗
2026-01-22Hyep Ivan, Chief Financial Officer$34,158
1,882 shplan 2025-02-13144 ↗
Form 4, 2026-01-26: sold 1,882 at $18.15 Form 4 ↗
2026-01-15Cohlhepp Ryan, President, COO & Interim CEO$2,685
149 shplan 2025-02-12144 ↗
Form 4, 2026-01-20: sold 149 at $18.02 Form 4 ↗
2025-12-22Hyep Ivan, Chief Financial Officer$164,404
9,200 shplan 2025-02-13144 ↗
Form 4, 2025-12-23: sold 9,200 at $18.31 Form 4 ↗
2025-12-15Cohlhepp Ryan, President, COO & Interim CEO$233,750
12,500 shplan 2025-02-12144 ↗
Form 4, 2025-12-16: sold 12,500 at $18.68 Form 4 ↗
2025-11-25Raben David, Chief Medical Officer$103,633
5,500 shplan 2025-02-12no Form 4 on file144 ↗
2025-11-24Mazumdar Claire, Chief Executive Officer$776,429
41,163 shplan 2025-02-12144 ↗
Form 4, 2025-11-25: sold 41,163 at $18.86 Form 4 ↗
2025-11-24Hyep Ivan, Chief Financial Officer$330,094
17,795 shplan 2025-02-13no Form 4 on file144 ↗
2025-11-24Raben David, Chief Medical Officer$101,475
5,500 shplan 2025-02-12144 ↗
Form 4, 2025-11-25: sold 11,000 at $18.65 Form 4 ↗
2025-11-21Hyep Ivan, Chief Financial Officer$10,981
605 shplan 2025-02-13144 ↗
Form 4, 2025-11-25: sold 18,400 at $18.54 Form 4 ↗
2025-11-21Cohlhepp Ryan, President, COO & Interim CEO$225,588
12,500 shplan 2025-02-12144 ↗
Form 4, 2025-11-25: sold 12,500 at $18.05 Form 4 ↗
2025-10-16Mazumdar Claire, Chief Executive Officer$453,761
24,103 shplan 2025-02-12144 ↗
Form 4, 2025-10-20: sold 24,103 at $18.83 Form 4 ↗
2025-10-15Cohlhepp Ryan, President, COO & Interim CEO$226,601
12,500 shplan 2025-02-12144 ↗
Form 4, 2025-10-16: sold 12,500 at $18.16 Form 4 ↗
2025-10-15Mazumdar Claire, Chief Executive Officer$250,391
13,289 shplan 2025-02-12no Form 4 on file144 ↗
2025-10-13Mazumdar Claire, Chief Executive Officer$216,545
11,445 shplan 2025-02-12144 ↗
Form 4, 2025-10-15: sold 24,734 at $18.88 Form 4 ↗
2025-10-09Hyep Ivan, Chief Financial Officer$114,764
6,415 shplan 2025-02-13144 ↗
Form 4, 2025-10-10: sold 6,415 at $18.23 Form 4 ↗
2025-10-09Raben David, Chief Medical Officer$405,900
22,000 shplan 2025-02-12144 ↗
Form 4, 2025-10-10: sold 22,000 at $18.45 Form 4 ↗